Stock Report

Download full stock data and analysis for free Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Pear Therapeutics Inc (PEAR) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.01

up-down-arrow $0.00 (-15.38%)

As on 20-Jun-2023 09:30EDT

Market cap

info icon

$4 Mln

Revenue (TTM)

info icon

$13 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

4.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -37.18 -39.04 78.89 -26.95 --
EBIT -9.50 14.82 -1.76 -223.92 --
Net Profit 182.80 131.37 114.09 -189.38 --
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info -1,433.33---971.72-2,511.53-816.75
Net Margin info 54.51----54.51--
Return on equity info 0.32---39.23-53.1093.29
Return on Capital info -14.11---25.49-128.86112.01
Return on Assets info -32.38---16.2414.80-95.71
Debt to Equity (x) info ----1.230.31-0.14

Profitability

View Detailed Peer Comparison

ROCE

-25.49

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-25.49
-128.86
112.01
--
--
Peer Median
--
--
--
--
--
ROE

-39.23

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-39.23
-53.10
93.29
--
--
Peer Median
--
--
--
--
--
ROA

-16.24

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-16.24
14.80
-95.71
--
--
Peer Median
--
--
--
--
--
EBIT Margin

-971.72

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-971.72
-2,511.53
-816.75
-97.05
--
Peer Median
--
--
--
--
--
Net Margin

-187.02

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-187.02
54.51
-1,234.42
102.10
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

2.02

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
2.02
-0.55
-0.71
--
--
Peer Median
--
--
--
--
--
EBIT Growth

-16.71

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-16.71
-37.89
-142.52
--
--
Peer Median
--
--
--
--
--
Net Profit Growth

-197.32

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-197.32
121.06
-448.44
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

1.23

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
1.23
0.31
-0.14
-0.23
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.96

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
0.96
0.30
-0.14
-0.07
--
Peer Median
--
--
--
--
--
Current Ratio

1.48

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
1.48
3.93
3.10
6.26
--
Peer Median
--
--
--
--
--
Quick Ratio

1.47

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
1.47
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

-31.69

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
-31.69
-25.50
-29.92
--
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

54.70

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
54.70
42.63
2.74
3.10
--
Peer Median
--
--
--
--
--
Asset Turnover

0.09

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
0.09
0.03
0.08
--
--
Peer Median
--
--
--
--
--
Receivable days

125.70

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
125.70
89.01
24.62
11.31
--
Peer Median
--
--
--
--
--
Inventory Days

3.08

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
3.08
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

113.14

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
113.14
220.28
765.58
986.69
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

15.64

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
15.64
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

EV/EBITDA

0.13

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Pear Therapeutics Inc (PEAR)
0.13
0.96
--
--
--
Peer Median
--
--
--
--
--
loading...
loading...